Old Web
English
Sign In
Acemap
>
authorDetail
>
Abby E. Odle
Abby E. Odle
University of Iowa
Medicine
Antibody
Coronavirus disease 2019
Virology
Neutralizing antibody
6
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The development of Nanosota - 1 as anti-SARS-CoV-2 nanobody drug candidates.
2021
eLife
Gang Ye
Joseph P. Gallant
Jian Zheng
Christopher Massey
Ke Shi
Wanbo Tai
Abby E. Odle
Molly A. Vickers
Jian Shang
Yushun Wan
Lanying Du
Hideki Aihara
Stanley Perlman
Aaron M. LeBeau
Fang Li
Show All
Source
Cite
Save
Citations (3)
Author response: The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
2021
eLife
Gang Ye
Joseph P. Gallant
Jian Zheng
Christopher Massey
Ke Shi
Wanbo Tai
Abby E. Odle
Molly A. Vickers
Jian Shang
Yushun Wan
Lanying Du
Hideki Aihara
Stanley Perlman
Aaron M. LeBeau
Fang Li
Show All
Source
Cite
Save
Citations (0)
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors
2021
medRxiv
Molly A. Vickers
Sariol A
Leon J
Alexandra Ehlers
Locher Av
Dubay Ka
Collins L
Voss D
Abby E. Odle
Holida M
Anna E. Merrill
Stanley Perlman
Knudson Cm
Show All
Source
Cite
Save
Citations (0)
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2
2020
Gang Ye
Joseph P. Gallant
Christopher Massey
Ke Shi
Wanbo Tai
Jian Zheng
Abby E. Odle
Molly A. Vickers
Jian Shang
Yushun Wan
Aleksandra Drelich
Kempaiah R. Kempaiah
Vivian Tat
Stanley Perlman
Lanying Du
Chien-Te K. Tseng
Hideki Aihara
Aaron M. LeBeau
Fang Li
Show All
Source
Cite
Save
Citations (3)
1